23andMe therapeutics group to better understand common and rare diseases

Personal genetics company 23andMe (Mountain View, CA) has created a new therapeutics group that aims to use human genetic data as the starting point for identifying new therapies for both common and rare diseases. The group, in connection with the company's research platform, will lead to better understanding the biological mechanisms of disease and accelerating the discovery of novel treatments through human genetics.

Related: 23andMe direct-to-consumer genetic test receives FDA clearance

Leading the new group will be Richard Scheller, Ph.D., whom the company appointed as its chief science officer and head of therapeutics. Scheller retired in December 2014 from a distinguished 14-year career as an executive at Genentech, where he was the executive VP of research and early development. There, he led the company's research strategy, drug discovery, business development, and early drug development activities (through proof of concept in the clinic) around oncology, immunology, neuroscience, and infectious disease.
 
When Scheller assumes his post at 23andMe in April 2015, he will help build a dedicated research and development team.

Update: In April 2015, the company also appointed Robert Gentleman, Ph.D., as its VP of computational biology, a role in which Gentleman will focus on the exploration of how the human genetic and trait data in the company's database can be used to identify new therapies for disease. He will collaborate with Scheller and others to help the newly formed therapeutics group utilize data analytics and theoretical models to identify trends and ultimately advance the drug research and discovery process.

-----

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

New bioimaging technique offers clear view of nervous system

Scientists at Ludwig-Maximilians University have developed a technique for turning the body of a deceased rodent entirely transparent, revealing the central nervous system in unprecedented clarity....

Fluorescent jellyfish proteins light up unconventional laser

Safer lasers to map your cells could soon be in the offing -- all thanks to the humble jellyfish. Conventional lasers, like the pointer you might use to entertain your cat, produce light by emittin...

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Fluorescence microscopy helps provide new insight into how cancer cells metastasize

By using fluorescence microscopy, scientists have discovered an alternate theory on how some cancer cells metastasize.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World